HALT-C TRIAL

这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金， 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 慢性丙型肝炎是一种影响肝脏的长期病毒感染，可能导致永久性肝损伤，偶尔还会导致肝癌。这项研究的目的是比较长期维持治疗(3-1/2年)和不治疗的安全性和有效性。这些患者感染的慢性丙型肝炎患者在之前的疗程治疗中未能清除血液中的病毒。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Chronic hepatitis C is a long-lasting viral infection affecting the liver which may lead to permanent liver damage and, occasionally, to liver cancer. The purpose of this study is to determine the safety and efficacy of using long-term maintenance therapy (3-1/2 years) with PEG interferon compared to no treatment in subjects infected with chronic hepatitis C who have failed to clear virus from the bloodstream with previous courses of therapy.